Others in the same group lost less than 15%
or adults with overweight and at least one weight-related health condition such as Type 2 diabetes, high blood pressure, or high cholesterol Lowers the risk of major cardiovascular events in adults with both heart disease and obesity or overweight Common side effects of Wegovy are nausea, vomiting, diarrhea, constipation, stomach pain, indigestion, burping, bloating, gas, headache, tiredness, and dizziness
Transferrin saturation, serum iron, and ferritin in heart failure: prognostic significance and proteomic associations
Mioduchoski, FNP-BC, with physician-supervised care protocols and a focus on safe, individualized treatment planning
[Crossref] [PubMed] Mollan SP, Tahrani AA, Sinclair AJ
Even though there are studies showing an effective and safe reduction of glycaemic parameters with initial combination therapies with DPP-4 inhibitors, initial combinations are not generally recommended in the new treatment recommendations (7072, 7685)